Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical total assets
Total assets on the balance sheet at the end of each period.
Strata Critical Medical's total assets was $332.70M at Jun 30, 2026. For fiscal 2025 it was $325.47M, up 26.8% from the year before. The highest annual figure on record is $343.39M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $325.47M | +26.8% |
| FY2024 | Dec 31, 2024 | $256.68M | -13.0% |
| FY2023 | Dec 31, 2023 | $294.94M | -14.1% |
| FY2021 | Sep 30, 2021 | $343.39M | +1838.4% |
| FY2020 | Sep 30, 2020 | $17.72M | -93.6% |
| FY2019 | Sep 30, 2019 | $276.99M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $332.70M | +29.0% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $327.62M | +30.8% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $325.47M | +26.8% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $335.08M | +18.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $257.92M | -8.0% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $250.55M | -11.4% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $256.68M | -13.0% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $282.95M | -10.9% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $280.33M | -12.4% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $282.79M | -12.3% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $294.94M | -14.1% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $317.51M | -8.3% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $320.18M | +14.9% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $322.43M | +1720.1% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $343.39M | +23.4% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $346.15M | +24.3% |
| Q1 FY2021CQ4 2020 | Mar 31, 2021 | $278.76M | +0.6% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $17.72M | – |
| Q2 FY2020CQ1 2020 | Jun 30, 2020 | $278.37M | – |
| Q1 FY2020CQ4 2019 | Mar 31, 2020 | $278.37M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $276.99M | – |
See a number that looks wrong?